Mohit Motiwale

Mr. Mohit Motiwale

Punjabi University, Patiāla, India
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
MMMohit Motiwale
Mohit Motiwale
NYNeetu Singh Yadav
Neetu Singh Yadav
SKSushil Kumar
Sushil Kumar
TKTushar Kushwaha
Tushar Kushwaha
GCGourav Choudhir
Gourav Choudhir
DSDr. Pradeep K. Singour
Dr. Pradeep K. Singour
SARS-CoV-2 is liable for the worldwide coronavirus disease (COVID-19) exigency. This pandemic created the need for all viable treatment strategies available in the market. In this scenario, computer-aided drug design techniques can be efficiently applied for the quick identification of promising drug repurposing candidates. In the current study, we applied the molecular docking approach in conjugation with molecular dynamics (MD) simulations to find out potential inhibitors against Mpro of SARS-CoV-2 from previously reported SARS-3CL protease inhibitors. Our results showed that N-substituted isatin derivatives and pyrazolone compounds could be used as a potent inhibitor and may possess an anti-viral activity against SARS-CoV-2. However, further experimental investigation and validation of the selected hits are required to find out their suitability for clinical trials. Communicated by Ramaswamy H. Sarma

1 February 2022 in Phytomedicine Plus
Verified
Journal Article
Open access
AMAjay Kumar Meena
Ajay Kumar Meena
RIR. Ilavarasan
R. Ilavarasan
RSRavindra Singh
Ravindra Singh
DPDeepesh Parashar
Deepesh Parashar
MMMohit Motiwale
Mohit Motiwale
KDK.S. Dhiman
K.S. Dhiman

18 November 2021 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
AMAjay Kumar Meena
Ajay Kumar Meena
MMMohit Motiwale
Mohit Motiwale
RIR. Ilavarasan
R. Ilavarasan
APAyyam Perumal
Ayyam Perumal
RSRavindra Singh
Ravindra Singh
KDK. S. Dhiman
K. S. Dhiman

28 December 2021 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
AMAjay Kumar Meena
Ajay Kumar Meena
ASArjun Singh
Arjun Singh
IRIlavarasan R.
Ilavarasan R.
MMMohit Motiwale
Mohit Motiwale
RSRavindra Singh
Ravindra Singh
Narayanam SrikanthNarayanam Srikanth
Narayanam Srikanth
Ayurveda is an ancient science of India and helps the human body to keep fit while providing cures from indigenous plants, animal and mineral origin products for various ailments. In Ayurveda literature, Berberis aristata has been described as a major plant possess antidiarrheal, antimicrobial, antiprotozoal and antitrachoma activity and used in for several remedies including diarrhea, chronic rheumatism, jaundice, skin diseases, syphilis and urinary disorders. Berberis aristata contains photoactive constituents such as berberine, oxyberberine, berbamine, aromoline, a protoberberine alkaloid karachine, palmatine, oxycanthine and taxilamine and tannins, sugar, starch. The present study has been designed to develop a quality control protocol for the coded Ayurvedic drug by analyzing the reference standard of bioactive compound present in the formulation and respective ingredient. The Rf value of berberine chloride reference standard 0.05 was visible in test solution of Berberis aristata stem as well as in coded Ayurvedic drug extract and found comparable under UV 254 nm and 366 nm, respectively. The quantitative evaluation revealed the presence of berberine chloride in the coded Ayurvedic drug and Berberis aristata DC stem extract was 0.1261% and 5.3936%, respectively.

2 January 2023 in ChemistrySelect
Verified
Journal Article
Closed access
HSHimani Sharma
Himani Sharma
BRBaddipadige Raju
Baddipadige Raju
GNGera Narendra
Gera Narendra
MMMohit Motiwale
Mohit Motiwale
BSBhavna Sharma
Bhavna Sharma
OSOm Silakari
Om Silakari

31 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ATAbhay Tiwari
Abhay Tiwari
GSGarima Singh
Garima Singh
GCGourav Choudhir
Gourav Choudhir
MMMohit Motiwale
Mohit Motiwale
NJNidhi Joshi
Nidhi Joshi
DSDr. Pradeep K. Singour
Dr. Pradeep K. Singour
Vitamin D’s role in combating the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus causing COVID-19, has been established in unveiling viable inhibitors of COVID-19. The current study investigated the role of pre and pro-vitamin D bioactives from edible mushrooms against Mpro and PLpro proteases of SARS-CoV-2 by computational experiments. The bioactives of mushrooms, specifically ergosterol (provitamin D2), 7-dehydrocholesterol (provitamin-D3), 22,23-dihydroergocalciferol (provitamin-D4), cholecalciferol (vitamin-D3), and ergocalciferol (vitamin D2) were screened against Mpro and PLpro. Molecular docking analyses of the generated bioactive protease complexes unravelled the differential docking energies, which ranged from −7.5 kcal/mol to −4.5 kcal/mol. Ergosterol exhibited the lowest binding energy (−7.5 kcal/mol) against Mpro and PLpro (−5.9 kcal/mol). The Molecular Mechanics Poisson–Boltzmann Surface Area (MMPBSA) and MD simulation analyses indicated that the generated complexes were stable, thus affirming the putative binding of the bioactives to viral proteases. Considering the pivotal role of vitamin D bioactives, their direct interactions against SARS-CoV-2 proteases highlight the promising role of bioactives present in mushrooms as potent nutraceuticals against COVID-19.